Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 246 studies with search of: | Estonia |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
21 | Completed |
Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus
|
||||
22 | Active, not recruiting |
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
|
||||
23 | Completed |
A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients
|
||||
24 | Completed |
Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
|
||||
25 | Completed |
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
|
||||
26 | Completed |
CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE With An Adjustable Maintenance Dose Of SYMBICORT
|
||||
27 | Recruiting |
ALTTO(Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation)Study; BIG 2-06/N063D
|
||||
28 | Completed |
A Comparison of Sertraline-Reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.
|
||||
29 | Recruiting |
Study Evaluating the Safety and Efficacy of a Once-Daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections
|
||||
30 | Recruiting |
Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
|
||||
31 | Recruiting |
Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis
|
||||
32 | Recruiting |
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
|
||||
33 | Completed |
Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive
|
||||
34 | Recruiting |
A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.
|
||||
35 | Completed |
A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.
|
||||
36 | Recruiting |
Randomized Placebo Controlled Trial of Budesonide-MMX™ 6 mg and 9 mg in Patients With Ulcerative Colitis
|
||||
37 | Completed |
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
|
||||
38 | Completed |
A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections
|
||||
39 | Recruiting |
Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
|
||||
40 | Active, not recruiting |
Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
|
Previous Page (1-20) | Studies Shown (21-40) | Next (41-60) |